KKR has acquired Karo Healthcare for $3 billion, reflecting the growing significance of women's intimate wellness products in the consumer health market.

Information on the Target

Karo Healthcare is a pan-European consumer health company that specializes in women's intimate wellness products. Since its acquisition by EQT in 2019, Karo has evolved from a regional specialty-pharmaceutical operation into a prominent player in the consumer health sector. The company offers a range of products designed to address women's health concerns, particularly in the realm of intimate care, with leading treatments for conditions such as bacterial vaginosis (BV).

Karo's hero products meet a significant clinical need in a space that has traditionally been underserved. This focus on intimate health positions Karo to capitalize on the growing market demand for women's health solutions.

Industry Overview in the Target’s Specific Country

The consumer health industry in Europe is experiencing dynamic growth, driven by increasing awareness and acceptance of women's health issues. As societal conversation